Note: Descriptions are shown in the official language in which they were submitted.
: `q WO g2~2232~ PCl /U!~;92/04706
2 1 ~ 7
IN51~:RTI~ Pl~rl~IONS IN ~~T~IA
Thi s application i~ a corltinuation-in-part of applioation
Serial No. 714, 656, fil~d June 13, 1991.
Thi~ in~?en~on r~late~s~ to mutagene~i~ of mycobacteria. More
particularly, this invention relate3 to the ~eneration of
in~ertional mutzltioDs in mycob~cteria.
Certain mycobacteria r~!present major pathoqens of man and
ar~lmal~. For ~xa~ple!~, tub~r~:ulo~ ge~s:ally cau~ed in humans
by; Mvoobacteriu~_ub~rculoE~is, and in cattl~ by ~h~i~
; bovis, which may al~o ba~ ~ran3mitted ~o huu~an~ and other anisnals .
; the c~us~tlve ~çlent of lep~o~y. M~
t~aberculosi~ and myeo~ac~eria of th~ a~ ntracellulare-
scrGful~c~ qroup (M~IS group) repre~ent major opportu~i~tic
pa~hoge!~s ~o ~ p~ti~t~ :w~h a~guired inL~nun~ d~~ciency: .~lrome
AIr~5). ~M. p~dotuberculo~i. is a ma~or pa~ogog~ of cattle.
On:~ oth~r h~nd, Bacille Calme~te Guerin, or BC:G, an
a~irul~t ~tr~in of M. bo~ri, is wi~ely u~ed in human v~lccin~s, .
ar~d in~particlllar t~:us~d a3 a live vac:cine, which i prot~tive
again~t~ubereulo~ :. E3CG :is the only ch~ldhood vacGi~e which is
curren~ly glven at b~ r~h, hg2~ a ve~ry low incldence of ad~er~e
e~Eect O arl~ can be u~-d r~p~a~edly in an indi~vidual ~ e . ~., in
multiple forms) . In ~ddi~on, 8C:G and o~her mycobacter a (e.g.,
nployed in vaccine~, hav~ ad~uva~t propcrties
among th~ b~a3t currently known and, therefore, stimulate a
SU~3SI ITUTE SHEET
211i% ~ 7
W092/22326 2 PCT/US9~/~7~6
recipient' 8 immune ~ystem to respond to antigens with great
effectivene~s
It ha~ been ~ugge~ted by Jacobs, et al, Nature, Vol 327,
No 6122, pgs 532-535 (June 11, 19~7) that BCG could be used as
a ho~t for the con-truction of recombinant vaccines In other
words, it wa~ suggested to take an exlsttng vacclne tin this case
against tuberculosi~) and e~pand its protective repetoire through
the introduction of one or ~ore gen~e from oth,er path~gens
Because BCG vaccines are administered a~ live bacteria, it is
e~sential that any foreign antlgen~, polypeptlde~, or protein~
expressed by the bacteria are not lo~t from ~he b-cteria
subsequent to vaccination
Transformati~on,~the process whereby naked DNA i~ introduccd
into bacterial cell-, has been carried out ~ucces~fully in
mycobacteria Jaco~s, et al (1987), hereinabove cited, have
de~cribed transformatlon of mycob-cterla through chemical
~; method~, and Snapper, et al PNAS, Vol 85, pgJ. 6987-6991
(5ept-mber 1988) have~deccrlbed transformat~on of mycobacteria by
electroporation ~ Electroporation can gi~e from 105 to 106
tran~formantJ per ~g o~pla~mid DNA ~nd such pla~mid DNA' may
carry gen~ for reJl~tance~to antibiotic marker~ ~uch ~
kanamycln~(snapper~et~al 1988) to allow for ~elcction of
tràn~forméd~c~ ;fro~ non-tran~formcd cell~
Jacobs~, et ~1 (1987)~ and Sn-pper, et al (1988) have also
d-scribèd~th~ua~ of~clonlng vehlcl-~, such a~ pla~mld~ and
bact-rioph-go~, for~carrylng gene~ of~intercst into mycobacteria
Comblnatlon of~the~above-mentioned technigue~, along with
tand-rd tool~ o~ol-cular cloning~(e g~, u~e of re~triction
enzyme~,~etc ) allows~the clonlng of ~ene~ of intere~t into
vector~ and lntroduction of ~uch gene~ into mycobacteria To
xpre-~ thooe gene~, it i~ important to hav~ ~vaila~le ~ignals
for gene cxpre~lon, ln part~cular, tran~crlptlon promoter
element~ Such ptomoter element~ have been i~olated from
~ :
~ ' '
- : SUBSTITUTE SHEFr
W092/22326 ~ 2 i 7 PCT/US92/~7
-3-
myeobaeterial heat Jhoek genes, and have been u~ed to expre~s
foreign antigen~ in myeo~aeteria
Moleeular geneties of myeobaeteria, however ha~ only
recently begun to be developed, in part beeau~e myeobaeteria
pre~ent formidable ob~taele~ to genetie ~tudy in that
myeobaeteria, in general, elumD in eulture and grow very ~owly
The direet ~eleetion of mutant~ by employ1ng tran~po~on~ (also
known as random in~ertional mutagene~l~) ha~ been a u~eful
approaeh to the mutatlon-1 analy~i~ of mierobial pathogene~is
berg, et al , Curr TOD. Mlerobiol ~nmunol , Vol lla, pg~.
11 (1985); Taylor, et~al , J ~aeteriol, Vol 171, pgs
1870-1878 (1989); Fields, et al , Seienee, Vol 243, p~s
1059-1061 (19~9);~ Bernardlnl, et al , Proc Nat Aead Sci , Vol
86, pgs 3867-3a71 (1989));~ ~uch selectlon of mutant~, however,
had not been de~crl~-d 1n myeobaeterla
Objeets of the pre~ent ~nvention lnclude the generation of
mutation~in myeobaet~ria~and/or the introduetion of heterologous
gene~ into myeobaeteria~; in~partieul~r, the generation of
mutation~ of myeobaeteria~employed in vaeelne~, ~ueh a~ BCG, as
well a8 the~generat10n of~mut~tion~ ln pathogen~e myeobaeteria,
sueh a~ M tubereulo~i~;or M le~rae, whereby ~ue~ mutations make
tbe myeobacter1a~non-pathogenlc Heterologou~ gene~ whieh may be
introdueed i~to the~myeobaeterla inelude, but are not limited to,
g-ne~for proteetive~antig-D~) for a~variety of pathogen~,
and~or f or other ther~peutie agent-
In~aeeord-ne~wlth~an a~peet of the pre~ent invention, there
provided a mNt~ted~myeobaeter~um ~elected from the ela~
eon~iting o mutated~M bovi~- B~CG, mutated M tubereuIosi~,
; and mutated M lePrae~ The term "mutated M bovi~- BCGn, or
"mutate~ BCG~, or nmutated M tubereulo~is~, or or "mutated M
le~rae~ as u~ed herei~n mean that the~M bovl~ - BCG,
M tuberculosl~, or ~ 9~ lnelude~ at }ea~t ono mutated gene
::~ ::
~ ::
; : '
:
~ SUBStlTUTE SWEET--
211i~7
W092/22326 ~ PCT/US921047
such that the expresslon or the function of the gene i~ varied
with respeet to the non-mutated gene ~n the parent ~train
Preferably, the myeobaeterium ls mutated through an
insertional mutation of a myeobaeterial gene The insertional
mutation of the myeobaeterial gene may be effeeted through
illegitimate reeombinatlon of DNA lnto the myeobaeterial
chromo~ome, or by ho~ologous reeombinatlon, or by the in~ertion
of a myeobaeterlal tr~n~po~on into a myeobaeterlal gene
Preferably the in~ertlonal mutatlon 1~ effeeted by illegitimate
;~ recombination of~ DNA ~lnto~ the myeobaeterial ehromosome
In aeeordanee with another aspect of the present invention,
there ls provided a mutated M bovis whleh is mutated through an
in ertional mut-tion of an M bo~ls gene The in~ertional
mutation of the~;M ~bovl~s~gené may be effeeted a~ hereinabove
described for mutated M bov~s-BCG, mutated M tubereulosis,
and mutated M le~rae
$he DNA whieh is~lntegrated into the myeobaeterial
ehromosome through lllegltimate reeombination may be a linear DNA
fragment or ma~ b~ a~eireular DN~ Preferably, the DN~ is a
linear DNA fragment
ApplieantJ have~found that lllegitlmate reeom~ination, which
is a~ rare phenorenom~in~prok~ryotes, may be effeeted in M bovis-
BCG and~M ~;tubeteulo~ by~transformlng BCG or M tuberculosis
with~a~linearized~plas~ld Transformation may be aeeomplished by
any meanJ~kno~n~to~those killed ln th~ art, sueh as, for
e~mple,~eleetroporat~on,~or by~ the;generation of protopla~ts
into~whieh~the tr-n-forming DNA is ins-rted, followed by
regeneratlon~of the cell~wall, a~ de~cribed in Jacob~ (1987) and-
Sn~pp~r~1988)
In one embodiment, ~the DNA which is integrated into the
mycobacterium chromo~ome through illegltimate recombinatlon
lnc~ludes a ~electable marker Selectable markers WhlCh may be
employed included a kanamycin re~i~tancc marker, a bleomycin
~ resi~tance marker, or~a hygromycin re~i~tance marker, or a
,:;`
~: SU8STITUTE SHEET
W092t22326 . 2 1 1 1 2 1 7 PCT/US92/04706
-5-
bacteriophage re~istance marker, ~uch a~, but not ~imited to,
mycobacteriophage LS, Ll, Bxbl, Bxb2, Bxb3, D29, or TM4
re~istance marker~.
In another embodiment, the DNA include~ at lea~t one DNA
~eguence which encode~ a.protein heteroloqous to mycobacteria.
The at least one DNA ~quence which encodeJ a protein
heterologous to mycobacterla may be DNA which iJ all or a portion
of a gene encoding protein(~) or polypeptide(~) of lnterest.
Proteins or polypeptide~ o intere~t, which may be encoded
by the at lea~t one DN~ ~equence include, but are not limited to,
antigen~, anti-tumor ag-nt~, enzyme~, lymphokines, pharmacologic
agents, immunopotentiator~, and reporter molecules of intere~t in
a diagno~tic context.
Antigens for which:the at lea~t on~ DNA ~equcncc may encode
include, but are not lim~ted to, MYcobacterium leDrae antigen~;
M~cobacterium tuberculo~i~ antlgens; Rlckettsia antlgen~; malaria
sporozoite~ and merozoit~J; dip~theria toxoids; tetanu~ toxoids;
Clostridium antig n~' L-l-h~ania antlgen~; Salmonella antigen~;
Borrelia antigen~; MYCObaCt~riWn africanum antigen~;
Mveob~cteri~um intracellulare~antlgen~; M~cobacterium avium
antig-n~;~ TreDonom~;antlg~n~;~Pertu~ antigen~; Schi~to~oma
antigen ; Filaria;antigen~; Herp~ viru~ antlgen~; ~nfluenza and
parainfluenza viru~::antigenJ; me~le~ vtru~ antigen~; mump~ viruq
antigen~; hepatiti~vlru~ ntlg n~; Shi~ella ~ntigon~; Nei~eria
antlgen~; rabie~:anti:qeno,~ polio viru~ antigen~; Rlft ttalley
::Fever viru- antigen-;~denguè vlruJ antigon~; Hum~n
Immunodeflci~ncy Vlru~ IV) antigen~; re~piratory Jyncytial
iru~ tRSV) antlqen-;~:;-nak- venom antlgen~: and ~ibrio cholera
antigen~. Enzym ~which~may be encoded include, but are not
mited to, Jterold enzyme~.
Anti-tumor agentJ whlch~may be encoded by the at leafit one
DNA ~equence include, but are not llmlted to, lnterferon-~,
intcrfer`on-B, or lnt~erferon- ~ and tumor necro~J factor, or
,
:
.
- SUBSTITUTE SHEET
W092/~232~ PCT/US92/~7
TNF. Lymphokines whlch may be encoded include, but are not
limited to, interleukin~ 1 throuqh 8.
Reporter moleeules which may be encoded inelude, but are not
limited to, lucifera~e, B-galaetosidase, B-glueurontdase, and
catechol dehydrogena~c.
Other peptides or protein~ whleh may be encoded by the at
least one DNA ~equence i~cludc, but are not llmlted to, those
which encode for s~res~ protein~, whleh ean be ~dministered to
evoke an immune re~pon~ or to induce toleranc~ ln an autoimmune
disea~e (e.g., rheumatoid arthritis).
In one embodiment the DNA which lneograte~ into the
mycobacterial chromo~ome through lllegitlmate recomination may be
derived from a plasm~d. The pla~mld may bc a shuttle plasmld
~which incLudes a~bacterial origin of repllcation ~uch as an
E coli origin of replicaeion, a Baclllus orlgln of repllcation, a
Sta~h~lococcu~ orlgin of~replication, a Stre~tom~cc~ origin of
replication, or a~pneumoeoccal origln of replication. The
pla~mid, in another enbodiment, may~lneludc a mycobacterial
origin of rep~llcael~on, or may~be a ohuttl~ pla-mid includ~ng a
mycobaeterial orlgin of replication plu~ a bacterial origin of
repl~ieatlon a~ herei~n-bove de~crlb-d. Preferably, the plasmid i~
linearized prior to inte~ration lnto the mycobactcrlal ehromosome
through~ille~gieim-te;recombinaelon.
In a preferred~e~bodlment, a linear DNA, such a~, for
example~ lin~-rlz-d~pl-smid, ls integr-ted into an M. bovis
chromo-ome, an ~ -8CG~chromo~ome or an M.tuberculo~is
chromo~ome, or n M.~ le~rae chromo~ome, such as, for example, a -
8CG ehromo-ome, throùgh~illegltimate reeomblnat~on. The DNA,
through ~ueh integraelon, will cau~e an lneertional mutation of a
gene(~) in the myeobaeterial chromo~ome. For e~ple the DNA may
cau~e an~ln~ertional~mueaelon of a gene eneoding an enzyme which
i8 e~Yential ln a blo~ chetlc pa~chway of a nutrlent or an amlno
acid. The tran~formed myeobacteria are then ~ereened in order to
::
.
SUBgrITUTF SHEET ---
W092t22326 2 i ~ i 2 1 ~ PCT/US92/04706
--7--
determine the gene( 8 ~ which lo mutated For example, the mutated
mycobacteria may be grown on minlmal media (wlthout amino acids)
and on media containing variou~ amlno acld~ to determine the
nutritional rcqu~rement~ of the mutated mycobacteria; i e , the
mutated mycobacteria may be ~creened for auxotrophy Once the
mutated gene i~ identlfled, the comp~emcnt (i e , non-mutated)
; gene is isol~ted and cloned into an expreo~lon vector The
expre~ion vector is then tran~formed into the mutated
mycobacterium, whereby the complement g-ne i~ expre~ed in the
mutated mycob~ct-rium, and the mutated myco~acterlum become~
prototrophic The expre~lon vector may al~o include a gene
;eDcoding for protein,or polypeptide heterologou~ to the mutated
mycobacterium Such~protelnJ or poly~peptlde~ may be tho~e which
~arc hereinabove de~cribed Selection for mutated mycobacteria
; containing the complement gene and a qene encod~ng for a
heterologous proteln or polypeptlde may thu~ be ba~ed on the
ability of'the~mutated~mycobacteria, lnto wh~ch the complement
and the heterologou~ g~ne~ are lntroduced, to ~urvlve, when ~uch
mut~ted mycobacteria aro grown on approprlate medla
In one embodiment,~the expre~ion~vector ~ a DNA which
c~ompri~e~a~ fir~t D~ ~equ-nce *hlch i~ a phage DN~ portion
onco~ing bacterioph-ge~integration into a mutated mycobacterium
chromo~ome, and a ~econd;~NA ~eguence whlch encode~ the
complèment~gene,~and~may further include a third DNA ~equence
encod~ng -t~l-a~t o~e~protein or polyp-ptide whlch i~ '
h-tero~logou-~to the~mutat-d~mycobacterlum in which the DNA is to
be~integrated ~ ~ ~
The~term~nph-q ~DNA portion," - u~ed herein mean~ that the
~ NA ~eguence i~ derived'~from~a phage and lack~ th~ DNA which i9
; re ~ ired for phag-~ rep~iicatlon
Bacteriophage~ from which the phage DNA portlon may be
derived~ lnclude, but~are~not llmlted to, mycQbacterlophage , such
a~ but not li~ited to the L5, Ll, Bxbl, Bxb2, ~xb3, D29, and TM4
mycob~acteriophage~;~the l~bda phage of E coll; the toxin phages
SUBS7 ITUTE SHEET
211i2i7
W092/22326 PCT/US92/~7~6
-8-
of CorYnebacteria; phages of ActinomYce~ and Norcadia, the 0C31
phage of StreDtomvce~; and the P22 phage of Salmonella
Preferably, the phage DNA portlon encode~ mycoba~teriophage
integration lnto a mycobacteriu~ chro~o-ome
Preferably, the fir~t DNA ~equence include~ DNA encoding
integra~e, which i8 a protein that provlde~ for integrat~on of
the DNA into the mutat d M bovi~ or mutated M bovi~-BCG or
mut~ted M tuberculo~i- or ~utated M leDr-e mycobacterial
chromo~ome Mo~t preferably, the fir~t DNA ~equence also
include~ DNA which ncode~ an attP ~ite
The DNA ~equence encoding the attP site, and thc integrase
provides for an inte~ration event whlch 1~ referred to a~
ite-~pecific integratlon~ DNA contalning the attP ~ite and the
; integrase gene i~capable of lntegration into a corre~ponding
~` attB ~ite of an M bovls-BCG, M tuberculo~i~, or M LeDrae
chromo~ome ~
It i~ to be~under~tood that the e~act DNA ~equence en~oding
the attP ~ite may vary~among different phage~, and that the exact
NA~equence ~ncodlng the~-ttB Jite may vary among M bovi~, M
bovi~-BCG, M tuberculo~ and M. Ievrae
The~integration event re~ult~ in the for~ation of two new
;junction ~ite~ called;~attL and at~R, each o which eontain part
of -ach~o f ~-ttP~and~ttB ` The in~erted and integrated non-phage
DNA;~which includ~- the;~flr~t, ocond, and prefera~ly third DNA
equencc~ fl;anked~by~the attL and attR Jite~ The in~ertion
and~int-gr-t~on~of~ th~phage DNA~portion re~ult~ in the formation
of tran-fors-d~mut-ted myeobacterium which inelude~ an
in-ertlonally aut~ted~myeob~eteriaI gene, a complement gene, and
préferably a D ~ ~r-qu-nee whieh encode~ a prote~n or polypeptide
which iJ heterologou~to myeobaeteria
The third DNA ~equenee *h{ch eneode~ a proteln or
::
polypept~de heterologou- to myeobacterla may be DNA which is all
or a portion of a géne~eneoding proteln(~) or polypeptide(~) of
intere~t, ~ueh aJ tho~e hereinabove de~eribed; DNA eneoding a
~ ,
::
::
SUBSTITUTE SHEET
W092/22~26 ~ i 7 PCT/US~2/047~6
_9_
selectable marker or ~arker~; or DNA encodlng both a selectable
m-rker or marker~ and at l~a~t ono prote~n or polypeptide of
intereJt .
Selectable m~rkorJ which may b~ ~ncoded ~nclude, but are not
limited to, th~ kanamycin re~l~t-nce m-rker, th~ neomycin
re istance marker, th~ chloramphenicol r~ tance marker, the
hygromycin re~i~tanc~ ~arker, or bact~rlophage re~i~tance
marker, such a~ tho~e h~rolnabove de~crlbed
The phage DNA portion, ~hlch lnclud~ the fir~t DNA ~eguence
encoding mycobacterium phag~ lntegratlon, und the ~econd DNA
~equence encoding the complement gene, and the third DNA
sequence, $f pre~ent,; eDcoding at lea~t one proteln or
polypeptide heterologou~ to mycobacterla, may be constructed
through geneti~ engineerlng technigue~ ~nown to tho~e skilled in
the art In one embodlment, the phage DNA portion may be a
pla~m~d includlng, in~addltlon to th~ DNA encoding integratlon,
the DNA encoding the complement gene, and, ~f pre~ent, the DNA
encoding a heterolo~ou~protein, an orlg~n of r~pllcatlon for any
of a wide ~ariety of organi m~ which lnclud~ ut i~ not limited
to,~ coli, StreDtomv~e~ ~pecle-, Baelllu~ ~p~cie~,
St~a~hvlo~occu~ ~p~eie~ Shlaella ~pccle~, Salmonella specics, and
variou~ peeie~ of pn u~ococci Preferably the pla~mid includes
an~orlgin~of replicat~on~for E coli~
The ~phage DNA portion :al~o may include a ~uitable ~romoter
Sult~ble~pro~ot~r~include, ~ut are not li~lted to, myco~aeterial
;promot-r~ Juch ~-~the BCG HSP60 and ~sP7a promoters; mycobactin
promoterJ of M tub~rculo~ and BCG, the ~uperoxide di~muta~e
promoter, the ~-antigen~promoter of M tuberculo~lr and BCG, the
MBP-70 promoter, the: :45 ~kda antigen promoter of M tuberculosis
and BCG; the mycob~acterl~l a~d pro~ot~r; th~ mycobacterial 14 kda
nd 12 kda antlgen~promoters; mycobacteriophage pro~oters such as
the Bxbl, B~b2, and ~xb3~promoterJ, the Ll and L5 promoter~, the
D29 promoter, and the TM4 promoter~; E coli promoter~; or any
other ~uitable promoter The selection of a ~ultable promoter is
SUBSTITUTE SHEET
wo 92/223262 1 ~ i 2 1 7 -lo- P~T/US92/04706
deemed to be within the scope of tho~e of ordinary skill in the
art from the teaching~ contained h~reln
The promoter ~equence m~y, in one embodiment, be part of an
expre~ion ca~ette which al~o snclude~ a portion of the gene
normally under the control of the promoter For example, when a
mycobacterial ~SP60 or ~SP70 promoter 1~ e~ployed, the expre~sion
ca~ette may include, in additlon to the promoter, a portion of
the gene for the ~SP60 or ~SP70 proteln When the expre~sion
cas~ette and the DNA encodlng a heterologou~ protein or
;~ polypeptide are expre~ed, the proteln expre~sed by the ca~setteand the DNA encoding the heteroloqous prot~in or polypeptide is a
fu ion protein of a frag~ent of a myeob-cterial protein (e g ,
the HSP60 or HSP70 proteln), and o the heterologou~ protein
Preferably, the tran~crlptlon inltlatlon ~ite, t~e ribosomal
binding ~ite, and the start codon, which provide~ for the
initiatson of the tran~lation of mRNA, are each of mycobacterial
origin The~top codon, which stop~ tran~lation of mRNA, thereby
termin-tlng the ~ynthe~i~ of the compl~ment prote~n and/or the
heterologou~ protein, and the tran~cription terminatlon ~ite, may
be of mycobacterlal orlgln, or of other b-ct~ri-l otlgln, or such
top codon and tran~crlptlon termination ~lte may be tho~e of the
DNA encodlng the comple ~ nt gene or DNA encodlng the heterologous
pro~te~n or polypept~de,~when Juch DNA 1~ pre~ent.
Such DNA~whIch lnclude~ a flr~t DNA ~equenee which i~ a
phage~DNA portlon~encoding bacteriophage integration into a
mycobacterium chr~o w ~om~, and a ~econd DNA ~egu~nce encoding a
complement~gene, and lf pre~ent, a thlrd DNA ~eguence encoding at
lea~t one protein or polypeptide which i~ hoterologou~ to the
mutaéed~ mycobacterlum~ln~;~whlch the DNA 1~ to be lntegrated i~
further de~crib~d ln~ppllc~tion Seri-l No 553,907, flled July
16,1990, the content~ o wh~ch ~r~ hercby lncorporatcd by
reference
~` In another embodlment, the e~pre-~ion vector lnclude~ DNA
which encodec tho compl ent gene, ~nd may furth~r include DNA
:
::
,
:
: SUBSTITlJTE SHEET
W092/22326 2 1 1 1 2 1 7 PCT/US92/04706
: s
wh$ch encode~ a proteln or polypeptlde heterologous to thc
mutated mycobacterium whlch e~prc~e~ the protein or polypeptide,
such as tho~e hereinabove descrlbed, and a promoter selected from
the clas~ con~isting of mycobacterial promoter~ and
mycobacteriophage promoters for controlllng expre~ion of the DNA
encoding the compl~mont gene and, if pre~ent, the DN~ enc ding
the heterologou~ protein or polypeptlde The mycobacterial
promoters may be thoso a~ herelnabove do~crlbed wlth re~pect to
the DNA wh$ch encode~ phaqe integratlon into a mycobacterium
chromo~ome The promoter may ~l~o be part of an expression
ca~sette which al80 includes a portion of the geno normally under
the control of the~promoter,~a~ herelnabovo doscrlbed Also, the
transrript~on initi~tion codon, the ribo~omal blndlng ~ite, and
the start codon, may each be of mycobacterlal origin, and the
~top codon, and the transcriptlon termlnatlon ~ite, may be of
mycobacterial or~gln, or~of other bacterlal orlgin, or thse stop
codon and tran~cript$on`terminatlon ~lte may be tho~e of the DNA
encoding the~c~ompl~nt gene, or of the DNA encodlng the
heterologou~ protein~or polypeptide, al~o a~ hereinabo~e
de-cribed ~
In~one~embodiment~,~the mycobacterlal prom~ter i~ a BCG
promoter
In another embodlment, tho heterologous proteln or
polypeptide may ~ ~a ~eLectable marker Such ~electable markers
include, but are~not llmlted to,~ the ~-galactosida~e marker, the
kanamycln~reci~tance marker, the chloramphenicol resi~tance
m-rker, the neomycln re-i~tance marker, the hygromyc~n re~istance
marker, or~a~bacterlophage re~l~tance marXer ~uch a~ tho~e
hereinabove de~cribed ~
~ n one embodi~ent, the expre~ion vector further include~ a
mycobacterial origln;of repllcatlon
In accordance wlt~ anothcr embod$ment, ~uch an oxpre~ion
,:
vector may be a pla~id The~pla~mid may be a non-~huttle
pla~mid, or may~be a ~huttle pla~mid which further include~ a
.~ :
SIJB51 ITUTE SHEET
W092~22326 2 ~ PCT/US92/~7Q6
..
-12-
bacterial origin of replication euch a~ an E coll origin of
replication, a BacilluJ orlg~n of repllcatlon, a Sta~hYlococcus
origin of replication, a streDtomYce~ orlgin of replication, or a
pneumococcal origln of repllcatlon
The vector may further lnclude a multlple cloning ~ite, and
the DNA encoding for the eo~plement gene and/or the DNA cncoding
for the heterologou~ proteln 1~ lneerted ln the ~ultiple cloning
~ite
Suc~ an expre~ion~v~ctor includlng a mycobacterlal promoter
or a mycobacteriophaqe promoter i~ further de~cribed ln
application Serial No 642,017, fi}ed January 16, 1991, which is
- continuation of appllcation Serial No 5S2,~28, filed July 16,
1990,~ now abandoned The content~ of applicatlon Serial No
642,017 are hereby incorporated by reference
In another embodlment, thc ~xpree~lon voctor which includes
~the complement gene and/or DN~ encoding for a proteln or
polypept~de which 1~ beterologou~ to mycobacterta i~ a shuttle
phaemid~vector, whlch repllcate~ a~ a pla~mld ln bactcria and as
a~phage~ 1n mycobac~ter1a~ In~on~ e~bodlment, the ~huttle pha~mid
vector~include~ two Jpecie~ of cohe~ve end site~ one for lambda
phage,~which~functionJ~in E coll; and one for mycob-cteria (eg ,
the~mycobacteriophage~TM)~wh1ch~function~ ln mycobacteria
P~referably,~uch Jhuttle~pha~mld vector ha~ a unlque ~ite (eg , a
uniqu~;;EcoRI site~ lnto whlch thc complement g~ne and/or DNA
enooding a protein~or~polypept1de heterologou~ to myco~acteria
may~be inJerted ~Ex ~ le~ of ~uch ~huttle pha~mid vectors are
urtb r~d~cr1bed~1n;Appl1c~tlon Serial No 361,944, filed June
5,~;~1989 the contentJ~;of whlch are hereby lncorporated by
reference
` It i~ al~o to be underJtood that withln the ~cope of the
present invention, the complement gene may be contalned ln one
expre~lon vector, and;a gene encodlng a protetn or polypeptide
;heterologou~ to mycobactoria may ~e contained ln ~nother
expre~ion ve~tor ~ ;
, ~ .
: :
~ SUBSTITUTE SHEET
W092/22326 ~ PCT/~S92/04706
-13-
As here~nabove sta~ed, the mycob~ctertum may include an
in~ertional mutatlon of a myoobacterial gene which i~ effected
through the i~ert~on of a mycobacterial tran~po~on into a
mycobacterial gene. rhu~, in ~ccordance with another aspect of
the pre~ent invention, there i~ provided a myco~acterial
tran~po~on whlch i8 capabl~ of in~erttng r-ndomly into a
mycobacterial chromo~ome to effect an ln~ertlonal mutation of a
mycobacterial gene, ~he ~ycobacterlal tran~po~on may, for
example, in~ert randomly into an M. bo~1~ chro~ome, an M.
bovi -BCG chromosome, an M. tuberculo~1~ chromosome, an M. avium
cXromo~ome, an M. le~rac chromo~ome, or an M. ~eomati~
chromo~ome. In one embodi~ent, the tran~pooon i~ the IS1096
tran~po~on of M. gmeomati~. The I51096 tran~po~on, whlch 1~
hereinafter de~cribe~, ig 2,275 ~p ~n length, and contain~ two
open reading frame~ which may encode pro~ein~ in~olved in
transpo~ition. Although ~he I51096 tran~po~on 1~ found in M.
smeomati~, it i~ contemplated that the tran~po~on may be employed
in generating in~ertion~l m~ ation~ in othQr ~pecieJ of
mycobacteria, ~uch ag tho~e hereinabove ment~oned.
The ter~ "tran~po~on" a~ uJed hereln, m~a~ a non-mutated
tran~po~on or ~ mut~ted tran~po~on in whlch a portion of the
tran~poDon ~eguenc~ ha~ bee~ deleted and/or replaced, and/or
wherein the tran~po~on contaln~ add~tlonal DN~ sequence(~).
In genor~l, a tran~po~on con~ain~ an l~verted repeat
eguence at each (5' and 3') end, and ~ gene(~ encoding a
tranBpos~ nzym~(~) between the in~ert~d repeat ~quence~. The
tran~po~a-o(~) act~ upon the lnverted repeat ~equen~e~ 80 as to
enable the tran~pogon~to remove lt~elf from a DNA (eg.,
chromosomal DNA, plagmid D~A, phage DNA, etc.) and insert or
tran~po~e into another DNA, or i~to another ro~lon of the s~me
DNA. In ~om~ in~tance , the trnn~po~on may al~o include gene(sS
encoding resolva~c~s~ a~d/or regulatory protein(s3 w~lch regulate
tran~po~ition.
SUBSl ITlJTE SHEET
2ili2~ 7
W092/22326 PCT/US92/04706
The in~ertional mutatlon, which 1~ eff~cted by a
mycobacterial tran~pocon, may be effected by random
transpo~ition, or "hopplng~ of a tran~pocon contained in a
mycobacterial chromo~ome from ono reglon of the chromocome into a
mycobacterial ~ene contained in another reglon of the chromosome,
or the tranJpo~an may be trancfeeted lnto the mycobacterium by a
variety of moanc Subcequent to tran~f-ction, the tr-n~po~on may
then in~ert at random lnto th~ mycobacterial chromo~ome to effect
an in~ertional mutatlon
The tran~po~on may be containod ln any pla~m~d or phaqe DNA
vector, including mycobacterlal vectora ~Nd mycobacter~ophage
vector~ In one embodlment, the trancpocon may be contained in a
mycobacterlal vector~ The vector may lnclude a mycob-cterial
promoter or mycobacterlophage promoter, ~uch a~ tho~e hereinabove
de~cribed In another embodlment, the tran~po~on may be
conta~ned within a mycobacterlal expre~clon vector or DNA which
encode~ phage lntegration lnto a mycobacterium chromo~ome, such
a~ hereinabove deccrlb~d, or the tran~po-on may be contained
within phage DNA whlch can repllcate withln one organiJm, but not
within th- organi~m~lnto whlch the phage i~ tran~f-cted
Alternatively, the~tranepo~on ~ay b~ cont~lned in a con~ugative
pla~mid which can~replicate ln ~a bacterlum other than a
mycob-cterl~m but~cannot replicate in mycobacteria For example,
the tran~po~on ~ay~be~contained ln a con~ugative pla~mid which
can~repllc~te tn a b~ct-rlu~ ~uch a~ E coll or Stre~tomYces~ but
cannot repllcate ln~M bo~i--~CC
In one e~bodi~ent,~a con~truct 1~ made in whtch the gene(~)
encoding a tran~po-a (-) and gene(~) encoding re~olvase(~)
and/or regulatory proteln~s) lf al~o pre~ent, 1~ removed from it~
~-, normal po~ltion ln the tran~po~on (betw~en th~ lnv~rted repeat
~equence~), and 1~ placed, ~n the re~ultlng con~truct, out~ide
the lnverted repeat --quences A ~elcctable marker, ~uch aR
tho~e herelnabove de~crlbed (eg , antiblotlc re~l~tance) i~ then
placed between the i m erted repeat ~egu~nce~ The tran~po~able
.
SUE~STITUTE SHEEF
W092/22326 2 1 ~ i 2 1 7 PCT/US92/04706
element thu~ includc~ the inverted rep~at ~equen e~ and the
-~electabl~ marker. Th~ con~truct i8 then cloned into a
my~obacterial expres~ion vector w~ich include~ a mycobacterial
origin of replication and may also include a my~obacterial
promoter or mycobacteriophage promoter ~uch ~ tho~e hereinabove
de~cribed. The mycob~terlal origln of replication of t~e
plasmid i~ then mut~t~d ~uch that the myeobacterial origin of
replication become~ temperature ~ensltive ( eg., thc pla~mid can
replicate at 30t: but not at 37C). l~e pla~mid is then
transfected into myco~acteria at 30C, and the mycobacteria are
selected for antibiotic resi~tan~. Antiblotlc resi~tant
colonie~ are then plated out on complete me~ium containing the
antibiotic at 37C. At 37C, the pla~mid containing the mutated
mycobacterial origin of replication cannot replicate. Tho8e
mycobacteria whi~h ~ur~ve are tho~e ~n whlch the transposable
e}ement containing th~ inverted repeat sequQnces and the
antibiotic resi~tance marker ha~ transpo~ed from the p~a~mid into
~e mycobacterial chromoso~e. Becau~e the tran~posa~e gene( 8 ),
as well a~ re~olv~e gen~(~) and/or regula~ory proteln gene(~),
if pre~ent, remains in the pla~mid, the tran~po~a~e gene(~) as
well a~ re~o~vnJe and/or regulatory protein gene(s), if present,
lo~t upon further replication of the my~obacter~a, and,
there~ore, the tran~po~ed con~truet, upon lnsertion into the
mycobacterial chromo~ome, will not undergo a~y ~ub~equent
tran~po~itio~.
: Altern~ti~ely, the con~truct here~n~bo~e de~cribed may be
cloned ~nto a vector wh~ ch cannot repllcate in mycobacter~a;
i.e., the vector doea not include a mycobacteri~l origin of
replication. The vector iQ then tranafeeted into mycobacteria.
Becau~e the vector ~ontain~ng the con~truct ca~not replicate in
mycoba teria, the vector will becom~ lo~t. The mycobacteria,
after tran~fectlon, are ~crecned for antl~lo~ic re~i~tance.
Tho~e myco~actcria which ~urYi~ ~rc tho~¢ in which the
tran~poaabl~ element containing the inv~rted repeat sequence~ and
the antibiot~c re~istance marker ha~ tran~po~ed from the plasmid
into the mycobacter~al chromo~ome. The tran~po~a~o gene(~, plus
resolva3e and/or re~ulatory protein gene(s), if present, remains
SUBS~ITUTE SHEET
211-~ 217
W092/22326 PCT/US92/04706~
in the pla~mid, and therefore i~ lo~t upon further replieation of
the mycobacteria, a~d, th~rofore, the transpos~d construct, upon
insertion in~o the mycobacterlal chro~o~ome, will not undergo
further transpositio~.
It i~ also conte~plat~d tbat a mycobactorlal tran~po~on may
be con~tructed whieh include~ at least one DNA ~equence which
encode~ a protein heterologous to myco~act~rla. Th~ at least one
DNA ~equence whi~h encode~ a protein het~rologou~ to my~obacteria
may be DNA which i8 all or a portlon of a geno encoding
protein(~) or polypeptld~(n) of ~ntere~t. Th~ proteins or
polypeptide~ of intorest may be tho~ h~rei~bove described. The
at least one DNA segue~c~ whlch encode~ a prot~in heterolo~ous to
: mycob~cteria may b~ under the control o a ~uitable promoter.
Such a transposon may be constructed by technique~ known to those
~killed in the art. The transpoEon may al~o include tranposa~e
gene(s) and/or a ~elect ~ le marker ~uch a~ tho~e horeinabove
descri~ed. ~lternatively, a C0~8trUCt m~y be formed in which the
transposase gene(~), and resolvase ~ne(~) and/or r~gulatory
protein gene(~) if pre~nt, 1 re~ov~d from a mycoba~teri~l
tran~po80n and place~ out~lde the inv~rted r~p~at ~equen~es, and
:::; the at leaQt on~ DNA ~quence encodlng a protetn h~terologous to
the mycobacteriu~, and preferably a ~el~ctable mark~r, i~ placed
between~the invert~d repeat ~quenccs. The con~truct may then be
: :placed i:nto a ~ector ~uch as hereinabove dc~cr~bed for
~ ,
~ transfection ~nto a~mycobact~ri~m. The tran~po~able eLement,
:: containing:the l~v~rted repeat ~e~uenre~, th~ ~t lea~t one DNA
equence enco~lng the protein or polypeptld~ hffterologous to the
mycobneterlu~, and the ~electable marker, may then inJert
randomly lnto the mycobacterium chromosome.
Once ~ c in~er~ional mut~tion of a my~obacterial gene i~
eff~cted by a ~ycob~cteri~l tr~n~po~on, tho myeobacte~ia may be
screened to determine the gene~(s) whlch 1B mut~t~d, by ~ethod~
; herein~bove describ~d. Once th~ mutat~d go~o ~ identified, the
complement gene may be iholated and cloned into ~n a~pres~ion
vector which 1~ tran~formed in~o tho mutated mycobacterium.
~ .
--- SUBSTITVTF SHEET
W092t22326 -17- 2 i ~ 12 ~ l PCT/US92/04706
It i~ al~o contemp~ated within the scope of the present
invention that in~ertional mutations may be generated in M.
tuberculosis of gene( 8) conferr~ng ~irulence upon M.
tuberculosiq, ther~by tr-n~formlng M. tub~rculosi~ from a
pathogenic to a non-pathoq~nlc organlsm. Such mutated
non-pathogenic M. tuberculosis org-nlsm~ may be employed in a
vaccine for protectlon again~t tuberculoal~. I desired, the
mutated non-pathogenic M. tuberculoels organl~ms may be subjected
to further insertionAl mutagene~ls, as h~relnabove described,
whereby auxotrop~y may b- conferred upon th~ mutated M.
tuberculosis Grgan~sm~ Such mutated M. tuberculosi~ organisms
may then be genctic-lly engineered through technlques such as
those here~nabove d-~cr1bed, so as to e~pres~ the complement gene
and/or genes for heterologous proteln~ of lntere~t, such as those
hereinabove de cribed.
Tho mutated mycobacteria herein~bove d~crlbed, which are
tran~formed with DNA whlch encote~ a protein(~) or polypeptide(s)
heterologous to ~ycob-cterla may be employed in the production of
a ~a~ccine or therap-utlc agent, dependlng upon the protein(s) or
po1ypeptide(s) expre---d~by the tran-formed mutated mycobacteria.
To form ~uch;- vaccine or therapeutlc agent, the transformed
mutated~ mycobacteria ~are ad~lnlstered in conjunctlon wl~h a
uitable pharmaceutlcal carrler. A~ repre~entatlve examples of
u~table carrier~ th~re~may be mention~d: min~ral oil, alum,
: ~: :
synthetic~polymor~ otc~. Vehicle~ for vaccine~ and the~apeutic
~H~ ~ agent~ aro w~ll known in the art and the ~election of a suitable
vehicle 1~ d~emed to be wlthin the ~cope of tho~e ~killed in the
art from the teach$n~y~ contained herein. Th~ ~el~ction of a
suitable vehicle i~ al~o dependent upon the ~nner ln which the
vaccine or therap~ut1c agont i~ to be ad~ini~tered. The vaccine
or therapeutic ag~nt may bo in the for~ of an in~ectable do~e and
~; may be adminl~ter~d ~ntramu~cularly, intravenou~ly, orally,
intrad~rmally, or by subcut~noous adminl~tratlon.
: ~ :
,
SUBSTITUTE SHEET
2 1 ~
W092/22326 PCT/US92/04706
-18-
Other mean~ for admlni~t~rlng the vaccine or therapeutic
agent should be apparent to tho~e ~killed ln the art from the
teachinq~ herein; accordingly, the ~cope of the lnvention is not
to be limited to a partlcular dellvery fonm
When the tran~formed ~utated mycobacterla are employed as a
vaccine, ~uch a vacclne ha~ 10portant adv~ntage~ over other
pre~ently available vacclne~ Mycobacterl- have, a~ hereinabove
indicated, ad~uvant propertle~ among the be~t currently known
and, therefore, stlmulate a reclpient'~ lmmune oy~tem to respond
with great efectivene~ Thl~ a~pect of the vacclne induces
cell-mediated immunity ~nd thu~ l~ e~peclally u~eful in providing
immunity against pathogen~ in ca~e~ where cell-medlated immunity
~appear~ to be crit1ca1 for re~i~tance Al~o, mycobacteria may
timulate~long-term~memory or immunity It thu~ may be po~ible
to prime Iong-lasting T cell memory, which ~tlmulate~ ~econdary
antibody re~pon~e~ neutrallzing to the infectlou~ agent or the
toxin Such prlming of T ~cell memory l~ u~eful, for example,
ga1nst t-tanu and~ dip~therl- to~ln~, pertu~ , malaria,
influenza Virt~ erpe~vlru~,~ r~blea~, Rlft Valley Fever virus,
dengue vlru~, measle~ ~ru~, Hum-n Im~unodeflclency Viru~ (~IV),
re~p1r~atory~yncyt1a1~v1ru~ hu~n tu~or~, ~nd cnake venom~
Another~advantage~in~employing my~cob~cterla tran~formed in
accordance with the~ pre~ent invention ~e a vaccine or a
ther~apeutic agent~ that~mycob~cterla ln general have a large
genome~(1 e~, appro~1m~te1y 3 x 106~bace palr~ in lengt~)
8ecau~e~ the~genome~ 1arge~ lt l~ ablc to accommodate a large
amount of DN~ from other ~ource(~), and may po~ibly be employed
to make~a vaccln- ~ /or therapeutlc agent containing DNA
equence~ encodlng more than onc antigen and/or therapeutic
agent
Thc inventlon will now be dc~cribed wlth rccpect to the
follow~ing examples; however, the ~copc of the present lnvention
is not intended to be llmlted thereby
Sl IR.~TITI ITF ~C~HFFT
W092/22326 ~ X 1 7 PCT/US92/047~6
....
~ L~ 1 (C~par~tl~)
Ra~do~ Shuttl~ Mut~gen~ o~
~. D~oo ~tl~
Chromo~omal DNA of M. ~meqma~ traln mc26 (J~cob~, Jr., et
al. Nature, Vol. 327, p~. 532-536 (1987)) wa~ partlally digested
with Msp I. Following ~ize ~el~ctlon, DNA insert~ of 4kb'to 7kb
were ligated to Cla ~-dige~ted pYUB36 (Figure 1). pYU~6
include~ a gene (~mp)~ for ampicillin reJistance, and an E. coli
origin of replication, a~d i~ a derlYattve of p8R 322 (Bolivar,
et al., Genc, Vol. 2, pg~. 95-113 (1977) in whlch a none~ential
1.9kb EcoRV to Pvu II~fragm~nt ha~ been deleted. After the DNA
in~ert~ have been ligated to ClaI-dige~ted pYUB36, the re~ulting
co~truct are tran~formed into E. ~oll ~ raln e~2 270, a
derivative of E. col~ ~tra~n X 2338 (Jacob~, et al., Proc Natl.
Acad. Sci., Vol. 83, pg~. 1926-lg30 (19~6)) into which transposon
TnS seq 1 (Nag., et al.,: G~ne, Vol. 64, pgs. 135-145 (1988))
Figure 2) iB in~erted~at:an unknown loc~tlon of the chromo~ome.
Tn5 Se~ 1 encodes the~neo gene which confer~ kanamycin re~i~tance
o~both~E. coli and mycobacterla (Snapper, ot al., Proc. N~tl.
Acad.~Sci., Vol.~S,~ pg~. 6987-6991 (198~)), perm1t~ selection of
in~e~rtion~;~nto DNA seguence~ cloned in~o pla~mld vectors u~ing
ts~neomycin~hyper-rcsl~tance phenotypc (Berg, et al., Geneticq,
Vol.~l~OS, pg8~ 813-828~(1983)), ~nd TnS~eql lac~ the cryptic
gene pre~ent in~Tn5 whlch~encsdeJ strepto~yc~n r~ t~nce, which
n~lmport~nt b10haz~rd con~ideration for th~ genetic
en~ine~rtng of M. tuberculo~ train~a~hereinafter de~cri~ed.
U;.~S.;Fed~. R~ie~ar,~Vol. Sl, pg. 16957). The transformed E.
co1i org~ani~m~;-re p1~te~ on ~-agar medium containin~ both
ampi~illin and kanamycin~at concentra~lon~ of 40 ~g/ml and 50
g/ml, r~spe~tively. About 30~,000 lndi~dual tra~formant~ were
pooled and ~Ample~ were~dlluted lO 3 into 20 independent 5 ml
culture~ and lncubated~at 37C o~ernight. A 200 ~l 8ample from
each ov~rnight cultur~ yielded approximately lO00 colonie~ on
L-agar - ~taining 250 ~g/~l neomycin, whereby ~uch colonies were
:
SllJBStITUTE SHEET
W092/22326 2 1 1 1 2 1 7 -20- PCT/US92/~706
~elected for neomycin hyper-re~l~tance, whieh i~ conferred
through tran~po~ltion of TnS ~eq 1 from the E. coli chromosome
into the tran~fecting pla~mid~. Pla~mld DNA from the neomycin
hyper-re~i~tant colonl~ wa~ l~olated ~ de~cribed in Birnboim,
Method~ in En~moloqv, Vol. 100, pg~ 243-255 (1983), and was
re-transformed into E. eoll ~train X2338, and pla~mid DNA was
subsequcntly l~olated and prepar.ed from the tran~formant~., The
Tn5 ~eq l-mutagenized pl~id ~lbrary wa~ then electroporated
into either M. smeomati~ ~traln mc26 or M. ~meo~ati~ strain
mc2l55 (Snapp~r, et al., Mol. Microbiol., Vol. 4, pg~. l91l-1~19
(l990)), and kanamycln-re~i~tant tran~orm~nt~ were ~elected on
K-agar (M~ddlebrook 7~10 agar ~upplemented with S mg/ml ca~amino
acids (Difco), 100 ~g/ml dlamlnopimellc ~cld, S0 ~g/ml thymidine,
40 ~g/ml uracil, 133 ~g/ml adeno~ine, 0.2% glycerol,
albumen-dextro~e complex, and 10 ~g/ml cyclohe~amide) containing
20 ~g/ml kanamycin. Kanamycln re~istant tran~formant~ were
obtained at a freguency:of 20 to 40 per ~g of pla~mid DNA. No
Xanamycin resl~tant coloni~-~were obtal~ed wlth a control
pBR322::TnS~eq 1 pla~mid (~al~o known a~ p ~ 244, a~ ~hown in
Figurc 13):which lacked:homologou~ DNA ~equence~. About 800
indlv~dual M. ~meomatl~ tran~formant~ were scre~ned for
auxotrophy by ~treaking onto minlmal Sauton medlum wlthout
a~p~ragine . The tran~form-nt~ were ~creened for auxotrophy as
de~crlbed ln D-vi~ t~-l., Manual for Genetic Enalnecrina:
Advanced~B~cterlal Genetic~, Cold Spring Harbor L~boratory
sao~), Appen~lx 2,~;pg~ 20~-2l0. Three auxotroph~ were obtained
from:thi-~ ~cr-en and their nutrltional requlrementr were
determin~d ~y pl~t~ng on Sauton agar platc~ ~upplemented with one
or the othe~r:of ll pool~ of nutrient~ uced for the auxonography
analy~iJ of E. col~ a-~de~cribed in Davic, et al. (1980). The
auxotroph~ obta~ned by~thi~ ~creen wer~ a methionine-requiring
auxotroph (M. ~meomatl~ straln mc23ll), a pyridoxine-requiring
auxotroph (M. ~meomatls ~train mc2313), and an auxotroph which is
incompletely char~cterlzed.
SUBSTITUTE SHEET
WO 92~2~326 -21- 2 1 ~ 1 2 1 7 PCI`/US92/~4706
~ IPr.lS 2
A. I~ol~tlon of B~G ~etaur Co~pl~ti~g
clon~ of M~ ~Qthlo~i~e ~u~cotroph
A genomic library of BCI:; Pa~taur (obt~ined from the WE~O BCG
Re~erence La~oratory at thQ St-t~n~ S~ t~ tut in Copenhagen )
was con3tructed by li~tlng 41c~-7kb M~p-I dig~sted chromo~omal
DNA fragment0 to ClaI-dige~ted pY~JE153 (Figure 3 ~, an E.
coli/mycobacter~ a ~huttl~ ~ector ineludlng an E. coli origin of
repl~ cation and a mycobacterial origin of repllc~tlon. Ligated
DNA' ~ were t~en introduced lI~to E. coll ctrain ec2270, and
pla~mids i~olated from the pool of E. coll a~ de~cribed in
~, et al . ( 19813 ), wQre electroporated lnto thc M ~meamati g
methionine auxo~roph, mc2311. Such plasmids, becau~e they
include a mycobacterial ort gin of replicatlon, do not integrate
into the myco~arterial c:hromo~lome, bu~ ~alf-replicat~ within the
mycobacterium. Pla~mid~ wh~ch conferrod prototrophy to mc2311
treferred to ~ met-comple~nting clone~) w~re i~olated as
~`~ de~cri~cd in Sn~v~er, ~t al. (198B)
B. Inactlvation of~ t-comPlem~ntin~ clone~.
The met-complementlng c}onc, na~d pYU~121, underwent
n~erti~onal inactivation in E. co}i by nQomycin hyp~r-re~i3tance
el-ction a~ herein~bovo de~crlbed ln Exa~ple 1. Individual
pYU8121 clones wore thcn ~creened for th~ lo~ of th~ir ability
to complem-nt tho mothlon~ne auxotroph~c mutatlon of mc 311
according to tl~ procedure de~cribed ln Davl ~, et al ~ ( ~980 ) .
C. Recombination in ~CG.
Plasmid~ pYU~lZl.24a (Figure 4), pYUB121.3 (Figure 5), and
pYUB121.2 tFigur- 6) were l~olated from m~thlonlne auxotrophic
mutant~ of mc2311 accorc~ing to thc proc~dure of SnaP~er, st al.
(1988). Each of pYUB121.24a, pYUB1~1.3, and pYUB121.2 was
dige~ted w~ th Ec:oRI . The EcoR~ fragm~nt-l conta~nlng TnS~eql from
each pla~mid wer~ subcloned lnto EcoRI d~ se~ted pYUB127 ( F~gure
'
SUBSTITUTE SHEET
wo 92,22326Z 1 1 i Z -1 7 PCT/US92/04~06
-2a-
7), an E. coli vector incapable of replic~ting tn mycobacteria,
to obtaln the correopon~inq pla~mlda pYUB149 (Figure ~), pYUBl47
(Figure 9), ~nd pYUBl46 (Figure lO), re~pectlvely.
BCG-P~teur wa~ el~ctropor-ted ao dercrib~d ~n Bernardini,
et al. Proc. Nat}. Acad. Sci., Vol. 86, pgr. 3~67-3~71 (1989)
with pYUB146, but with the following ~od~ficatlon~. BCG cultures
were ~ubcultured 1:50 in 50 ml MADC-TW broth (Snapper, et al.,
Proc. Natl._Acad. Sci., Vol. 8S, pg~. 6987-6991 (198B)) and grown
for 10 days at 37C. The harve~ted culture wa~ warhed first with
50 ml and~then with 25 m1 of cold glycerol. Following
centrifugstion, the flnal pellet w~ re~uop~nded ln 2.5 ml of
eold lOX glycerol and~0.4 ml uaed for each electroporation. 8CG
tran~formants were plated on Middlebrook 7H10 g~r ~upplemented
~; with albumin-dextroJe~complex (ADC), 0.2% glycerol, and 10 ~g/ml
cyclohexamide containing kanamycin ( 20 ~/ml) nd methionine (50
g/ml)~, a~ described~ln~Sna~Per~ et al. (19~
It was expccted;that~homologouJ recombinat~on re~ulting from
a~double~cro-~over~event, of a lInear DNA frag~ent containing the
Tn5;~eg~1-inacti~vated 0ethlonine gene would yiold kanamycin
re-i~t-nt,~methios1D-~au~otroph~ of BCG. Unexpeetedly, only one
;methionine auxotroph~of over 200 kanamyein-reel-ta~t
tran~formant~of~BCG-Pa~teur wa~ obta~ned from the tran~formation
of~lineari~zed pYUB146~eonta1ning ~n5 Jeq l-inaetlv-ted
methionine~geno. `The tra ~formant~ were sereened aeeording to
the~;~proeedure~of~D-vi~ et~a~ (l9~0). Sueh a re~ult indicates
that~a~hiqh d gree~o~ 11leg1t~m~te, or rando~ reeombination has
oeeurred~in;th~ ~tran~for~ed 8CG-Pa~teur organl~m~ ln that the Tn5
eq l inaetlvated~met~gene dld not reeombine, or integrate, into
; t e homologou~ ~èt ~lte~in the BCG chromo~ome.
~ , .
;-~
, ~
~::
::
~ . SUBSTIT~ITE SHEET
W092/22326 h ~ 7 PCT/US92/W706
^23-
BXA~PL~ 3
De~on~tr~tion of illegit~ate reco~blnatio~
Total chromo~omal DNA from th~ BC0 m~thionine auxstroph
obtained in Exampl~ 2, 80~etim~ herelnafte~ r~ferr~d to as BCG
strain mc2 576, dopo~ted a~ ATCC No. 55202, and from two other
kanamycin-re~stant tran~for~nt~ wa~ ub~ect~d to Southern blot
analy~is u~ing the 1.8 Xb XhoI DNA fragment from the BCG met gene
a~ a probe. (Figure ll). Thi~ pro~e d~tect~ an ~.5 kb fragment
in the wlld-type BCG chromo~ome, a~ ~hown ln Lano 1 of Fi~ure 11.
:homologous recombin~tion h~d t~ken plac~, a double cro~-o~er
between the chromo~ome and the lln~ar DNA from th~ transforming
pla~mid ~hould result in the replacome~t of ~h~ chromo~omal met
gene by the insertionally inact~vated gene. In Southern blot
analysis, the 8.5 kb XhoI fragment of the chromo~ome ~hould be
replaced by two ~w XhoI fragments, due to th~ pre~nce of an
XhoI site in Tn5 ~eq 1. The total l~ngth o~ the two fragment~
hould be a.~ Xb plu8 3.2 kb, Wlth 3.2 kb being the ~ize of TnS
eq 1. As shown ~n Flgure :11, however, ~h~ auxotroph, mc2S76
lane 23, a8 well: the two oth2r kana~ycln-resi~t~nt transformants
lan-- 3 and 4), cont~ln-d~three XhoI fragm~nts, one 8.5 Xb
frag~ent~and two fragments A and B, whlch are identical to that
pre-ent~in the Tn5 ~eg l:in-ctlvated BCG met clone. The~e
res~ult~ indicated th~t no doubl~ cro~-o~er occurred either in
ha~methionlne~auxotroph, mc2 576 or t~e ~wo other
X~n~my~in-ro~l~tant tr~n~formant~. Therefore, it i~ llkely that
the~1~1near DNA fr~g~t~cont~1n~ng tho Tn5~eq 1 inactivated met -
gené ha~ integrated ~lle~itimately lnto the 8CG chromosome.
Southern an~ly~ w~ al~o perform~ u~ing ~nd $ I I dige~ted
chromooomal~DNA a~d the ~ame XhoI m~t pro~e. A~ly~i~ of wild
typ~ BCG detect~ only one fragm~ (Figure 11, lanc 5). As 3hown
in Figure 11, th2 ~nternal Hind III fr~gment C of the donor
:(plaamid) DNA i~ con~erved ln all thr~e clone~ (lane~ 6, 7 and
8).~ Southern analy~i~ of Hlnd ~rI dlgoot~d chromoso~al DNA with
. ,
SUBSTITUTE SHEET
~ 7
W092/22326 PCT/US92/04~,;
-2~
the probe al~o detoct~ a flanking fraqment D, indicated by an
asterisk (~) t n the auxotroph (lane 6), and the prototroph~
(lanes 7 and 8), the ~ize of whlch depends upon the ~ite of
integration The ~ariation ln ~lzo of th~ flankinq fragment D
from dlfferent BCG rocombinant~ agaln lndicate~ that the donor,
or tran~formin~, DNA fragment 1~ lntegratlng randomly into the
BCG chromo~ome Al~o; th~ Southorn blot~ of XhoI and ~nd III
dige~ted chromo~omal DNA indieat~d th~t th~ po~ition of TnS ~eq 1
in the met gene of the donor wa~ un-lter~d, and that TnS seq 1
did not tran~po~e 1nto the BCG chromo~ome
Southern analy~ wa~ then carrled out upon Hlnd III
digested and XhoI dige~ted chromosomal ~CG DNA from nine
additional kanamycln-re~l~tance tran~formants, obtained by the
transformation of Linoarized~pYUB146, with the XhoI probe
obtained from the ~G met gene The three donor bands A, 8, and
C were d~tected in all nine clone~, indlcating th-t homologou~
recombination had~not~;occurred - Becau~e guanine ~nd cyto~ine
; nucl~eotide rich myco4a~cterial DNA may yleld ~ery large Hind III
;fr~gment~ which are not re~olvabl~ by ~tandard
gel-electrophore~i~, Southern blot an~ly~l~ wa~ performed by
hybridizing Ava;I~digeJted;`chromo~omal DN~ of the twelve clone~
wi~th~ uector probe,;~in~order to e-tabll-h the randomne~ of the
integration of band D~hereinabove mentioned A~ ~hown in Figure
12,;~the~probe det~et~d~four fragment~in pYUB146, ~lane ~), no
ragment~ in wild~typ~BCG~(lane 2) and two ~nternal fragmentq
which~were con~erv~d~in~each~clone (lane~ 3-14), and fragment~ E
and ~,~whlch~var~ed ln ~ize and Jhowed dlfferent pattern~ in each
c~lone, indicat~ng that~integration had taken place at random
si~te~, and thu~ e~tabll-hing that a hlgh degre~ of illegitimate
~recombination occur- in BCG
:~;: : : :
Z~MPLC 4
.
~;:SUBSI ITUTE SHEET
~ wo g2/22326 2 1 ~ ~ 2 1 7 ` PCT/US92/04706
-~S-
In thi~ exa~ple, experiments were undertaken to determine if
the illegitimate, or non-homologou~ recomblnatlon hereinabove
mentioned i~ a feature o~ BCG, or of the methionine (met) gene.
Tn5seql i8 ln~erted lnto pBR322 to form pYUB244 (Figure 13).
Equal quantitie~ of clrcular and linearl~ed pYUB244 were
electroporated into M. ~meo~at~. Such electroporation resulted
in no integration of elther clrcular or llne~r pYUB244.
Integration wa~ determlned by ~election for kanumycln re~istance
(Snapper, et al., tl9e8)), followed by Southern blot analysis.
Equal quantitie~ of circular and llneari~ed pYUB156 (Figure 14),
which ha~ TnS~eql in~erted ~n the complementlng met clone of M.
smeomatis, were then electroporated lnto M. ~meomati~. The
frequency of kanamycin-re~i~tant colonle~ u~ing both linear or
circular pYUB156 was about equal, a~ determined by the procedure
of SnaDDer, et al. (198~) fol~lowed by Southern blot an~ly~
Southern blot analy~i~ of ~i~ of the kanamycin-re~i~tant colonie~
of M. ~me ~ atl~ lndicated that integratlon of pYUB156 occurred at
the Eco RI frag~ent~of the chromo~ome ln all ~i~ colonic~. Such
re~ult~ indlcate th~t mycob~cterlaI homologou~ Jegucnce~ are
required for ~ntegratlon ~lnto the M. ~meomatl~ chromo~ome, and
that~integratlon in M.~ m~mat~ occur~through homologo~
recombination. ~ ~
Egual guantltlee~of ~lrcular and Eco RI dlge~ted pYUB244 and
TnS--gl` inactlvated BCG me~ clone~(pYU8146, p ~ 147, and
pYUBl49)~were~electroporated lnto BCG. Llnear fraq~ents but not
circular~pla~d~, of the above integratcd into the chromosome at
a~reguency of~ about 10 6 to~about l0~4/ug of DNA, irre~pcctive
of whether ~uch fragment~ contained~mycobacterial DNA.
ntegration i~ det~rmined ~y two crlteria: (1) that colonies are
kanamycin-re~i~tant; and~(2) that chromooomal DNA from
tran~formant~ hybrid~zed wlth the donor molecul~ a~ evidenced ~y
Southern blot analy~i~ as hereinabove de~cribed~
`A furthcr exp-riment wa~ then carried out ln which BCG wa~
electroporated wlth circular and linear pYUB244 and pYUB8 (Figure
:
:~ :
SUBSTITUTE SHEET
WO 92t223~ L i 2 1 ~ PCI~/US92/ ~ r
-2B-
15) pYUB8 l~ a pBR322 derivatlve i~ whlch the amp gene of
pBR322 i8 replac~d wlth the aph (kamamycln re~i~tance) gene of
Tn893 (Snapper, 1988), and whlch lack~ ~equence~ from Tn5~eql
In thi~ experiment, circular DNA of ~oth pYUB244 ~nd pYUB8 gav~
only 1 tran~formant per ug DNA, wherea~ llnearized and pY1~38 gave
12 and lO tran~formant~ per ug DN~, re~pectlvely, according to
the procedure of Snap~er, ot al (1988), followed by Southern
blot analysi~ The~e re~ults lndicate that the lllegitimate
recombination ln 8CG i~not dependent upon the tr~n~po~a~e
function of Tn5~eql
: DU~r~ S
In this example,~ e~ual gu~ntitie~ of circular and linear
pYUB244 and pYUB147~were electroporated into the virulent ~37Rv
~train of M tubercu10~ obtained from Dr Wilbur Jone~,
Center- for Dl~e~a~- Control, Atlanta, Georgia ) The re~ult~ of
uch electroporation indicated that the lln~ar form~ of ~oth
; pYUB147 and pYUB2~44~1ntegrated at a h~her freguency into the M
tuberculo~1- chromo~ome,~a~ detenmin~d by SnaoDer, et al 11988),
;followed by Southern blot~-naly~ls The above rc~ult~ indicate
thàt~illegltim~te~reco~blnatlon 1~ not re~trlcted to BCG
A~PL~ 6
Ieol~tlon~;-nd ch~r-cterlr-tion of BOG
iroleuciDe-leucln~-v~llDe au~otrop~ u d ng il}~gltl~atc
r~co~bl~tion
BCG-Pa~teur~wa~tran~for~ed vi- electroporation wlth
linearlzed pYU~244 ~ ~Following elec~roporation, the BCG cells
were plated on Middlebrook 7RlO agar containing 0 5mg/ml ca~amino
~, ~ ac~d~ and 20 ~g/ml kana~ycin Kanamycln-re~i~tant colonie~ were
screened for their ~billty to grow on Sauton mlnim-l agar, and
were~creen for auxotrophy a~ de~crlbed ln Davi~, et al (1980
Auxonography ana}y-l-~r~vealed tha~ one ~CG mut~nt, de~ignated
mc2716, requlred l~oleuclne, leucine, and vallne to grow
SUBSTITUTE SHEET
2 ~ 7
W092~22326 PCT/US92/047~6
~'
-27-
A genomic l~brary of BCG Pa~teur W~J con~tructed by ligating
4 kb-7 kb M p-I dige~ted chromo~omal fragment~ to Cla I-digested
pYUB53 (Figure 3), aJ h~reinabo~e descrlbed ~n ~xample 2.
~igated DNA' 8 wero then introduced lnto E. ~oll strain ec2270,
and pla~mid~ wero i~olat~d from the pool of ~. coli ~ des~ribed
in Snapper, et al. (19a8), and ~re ~l~ctropor~ted into BC~
~train mc2716, deposit~d on AT~C No. 55203. A pl~mid which
conferred prototrophy to mc2716 (referred to a~ an
i~oleucine-loucine-valino complement~ng clone), and which
contains the BCG i~v ge~o, wa~ i801at~cl a~ d~crib~d in Snapper,
et al. (1988). Thi~ pla~id i~ referr~d to as pYUB245 (Figure
16).
~XA~PLE 7
A. Con~tructlon of pl~ld contalDing
~: ~utat~d a~d ge~e of ~. o ~qæati~
: The aspartate ~emiald~hyde dehydrog~na~e (asd) gene encodes
an enzyme-that cataIyze6 ~n early stop ln th~ blo~ynthe~is of
~diaminopimelic acid ~DAP) f~om a~partate, and thu~ i~ a critical
component in the ~ell wall blosynthe~s o mycobacteria. A
train:cont~inlng a mutation ln the a d gene a~d it~
: complcmentation by the a~d gene on a recombinant DN~ vector would
repre~ent a u~eful ~uxotroph~c ~lectlon ~yst~m for maintenance
of~ vcctors in vivo. The M. ~meqmatl~ ~sd g~e wa~ cloned by
:;~: co~pl-mentlng un a~d ~utant of E. coll and determining the
nucleic acid Jequence aecording to the p~ocedure of J~Coba ~ et
al., PNAS, Vol. 83, pg~. 1926-1930 (1986). The a~d gene i5
earried on a 5 kb E~oRI fragment that ha~ two PstI 8ite8 in the
:, middle of the gene and two P~tI Jites flank~q th~ geneO The asd
gene wa~ cloned into the EcoRI slte o p Blue~ript RS ~
: (Stratagene, ~a Jolla, Ca~ifornla), and the re~ultin~ pla~mid was
designated pYU~114. (Figur~ 17). pYUB114 wa~ dige~ted with
: EcoRI, the large EcoRI fragment wa~ then i~olated and ligated to
- SVBSTITUTE SHEET
21~i217
WO 92~22326 PCr/US92/04706r
pGEM7Zf~ (Promega~ at the EcoRI si~e to fos~n pYUB160 (Figure 1~).
pYUB160 wa~ cut with P-ltI, ~nd a large fragm~nt ha~rlng a deletion
of 'che central 1, 637 bp of the aE~d gene wa~ i Yolated . pYUB8
(Figure 15) waa cut wlth ~tI, ~ PJtI kan Rc~ette wa~ isolated
from pYUB8 and ligated to tho large P~tI fragment from pYUB160.
T~e resulting lig~tion w~- tran~formcd into E. c:oli strain
D~ , seleeting for amp~ cillin ra~i~tanc~ carr~ ~d on pYUBli4 by
el~troporation. (DOWQr, ~t al., Nucl. Acids R~., Vol. 16, pgs.
6127-6145 ) . Transfor~ants w~r~ scr~en~d for replacement of the
central ~,637 bp of the al~d gene wlth the 1.3 kb XanR cassette.
The re~ulting plasmid, pYU~205 ( Figure 19 ), h~s a 1,1;37 bp
deletion of the a~d gene which i~ replaced by the a~h gene, ~uch
deletion and replacement gometim~ herelnaft~r referred to as
a~d :: aph. pYUB205 then wa~ cut with E~oRI and the large
f ragment i~olated from an agarose gel. The fragment was then
ligated to pYUB174 (Figure 20 ) which had been cut wlth EcoRI and
pho phata~ed w~th calf inteEstinal pho~phata~e ( ~oehrlnger
Mannheim, Indianapoli~, ~ndlarla). The pla~mid pYUB174, which
containQ the ~7-galacto~ld~e ger~e wa~ con~trueted ~y plaeing the
previously i~olated ~yco~acteriophage Ll promoter (Barletta, et
al . , J . Gen. Microblol . , Vol . _, pg~ . ( 1991 ) ) up~tream of a
trunc~ted ~-galacto~ida~e gene, to allow expr~ion of
galacto~ida~e ln mycobacteria. ~e r~ulting pl~id, pYUB21S
(Figure 21), contain~ the ~ a~d :: aPh gone an~ a truacated
galacto~ida~e ge~Q controlled ~y a mycobacteriophage-Ll
promoter.
8. Con~truction of ~C26g7
pYUB215 wa~ tr~n~formed by electropor~tlon into ~L~ a~S
"
strain mc~6 accordln~ to the proc~dure of JacobJ, ot al., Meth.
EnzYmol., Vol. 204, pg~. 537-55~ (1991~. ~hi~ tranJformation was
then plated out on M-~DC plat~J with 15 g/l bacto-a~ar (Jacob~,
et al., 1991), and containing kanamy~in, added at 10 ~g/ml and
5-bromo-~-chlsro-3-~ndoly~ D-~alactoJld~ (Xgal), added at 80
~g/ml, such ~dium al~o sometime~ herelnafter refer~od to a~
~BST1TUTE SHEET
~ wo g2~22326 2 1 1 ~ 2 ~ 7 PCT/US92/0470~
-23-
M-A~C-KX. The plate~ were incubated at 37C ~ntil colo~ies were
~isible. Blue colonie~ were picked and ~creened by Southern blot
analy~is to e~tablish ~ntegration of pYUB215.
When the pla~mid pYUB21~ wa~ lnitially tr~n~formed into M.
smeomati~, blue and kanamy sn ro~iJtant colonie~ wcre o~tained at
a frequency of 10-5 to 10-6 colonie~ per microgram of ~NA, as
compared to a tra~formation efflciency control vector pMV261
(S~over, et al., Natur~, Vol. 3~1, pg~. 456-460 ~1991)), on
M-ADC-KX agar conta~n~n~ DAP and ca~amlno acid~. No significant
number~ of white colonies were obtained abo~ ~ackground of 1
to 5 colonie~. The blue colonie~ wer~ inferred to be generated
by a ~ingle crossover recombination event between pYUB215 and the
M. smeomati 8 chromo~o~. The ~lngle cro~ov~r event likely
occurred between the M. ~meqmatl~ DNA ~equ~nces that flank the
gene that are identical to the ~L_rmeg~ DNA ~equences
that flank the a~d gene ln th~ M. ~moomati~ chromosome. Southern
analy~i~ of 8 independent tranJformant~ confirmed that pYUB215
had integrated on either side of ~he ~h gene, and one such
tran~formant w~ d~ignated ~train mc2687. The lnability to
generat2 replacement~ of the chromo~omal ~d gene w~th the mutant
a~d ~ h allele 1~ interpr~ted a~ lndicating that the a~d
gene i~ e~sentlal or that double cro~over ~v~nt~ occur at an
extremely low freguen~y in mycobacteria. ~he nece~Jity of having
imultaneous doubl~ cro~over e~ent~ can be obH~rved by
constructing the chromo~omal.~ a~d_:_ ~ph mutan~ in a two-~tep
proce~e. B~cau~me2687 ha~ alr~ady undergon~ a ~in~l~ crossover
event to int~rat~:pYUB215, a ~econd recombi~ation ev~nt ~etween-
: :
homolo~ous sequenc~ of the ~wo allele~ in the chromo~ome mayproduce the d~ired mutant. In the ~cond r~co~bination event,
~hown in Figure 23, th~ 3' end of the ~d ~n~ allgn~ lt3elf with
the 3' end of the ~ asd :: aDh gen~. Th~ two "3' end"
sequences are ho~ologou~. Through 1ntrachromo~omal
recom~i~ation, a circul~r pla~mid, which conta~n~ the sd gene,
the lac Z gene, and an E. coli origin of r2plication ~ori E)
SUBSTITUTE SHEET
'~1'11'~; (
W~92t2~26 PCT/US92/~70~....
..
-30-
should be looped ou~ of.~he chromo~o~e. Thu~ it Rhould be
po~sible to ~creen for intrachromosomal re~o~bination by the loss
of B-~alacto~idase whe~ the plasmid ~equence~ ~re looped out
during thi~ sv~nt b~c~u~ the pl~smid do~s not lnclud~ a
mycobacterial orl~in of r~plic~tion.
C. IJolatioa o~ ~ -g l~ctod ~a~
~uta~t~ of ~G 687
Strain m~2687 w~ grown up ln M-ADC-TW m~dlum and kanamycin,
and aliquots were plated out on M-ADC agar wlth th~ addltion of
:kanamycin and X-gal and ~creened for the productlon of white
colonies.
White mutant~ of mc2687, having loat ~-galactosida~e
activity, were obtained at a:frequency of 8 x 10 5 p~r cell.
Southern analy~i~ of 8 ~ I dlge~ts of total chro~o~omal DNA from
8 clones compared to ~C2687 i8 ~hown in Eigure 24. The DNA was
probed with pYUB215. As ohown in Eiguro 24, from the top of the
blot, in the mc2687 lane the~econd and fifth bands are flanking
BamHI fr~g~ent~ to the int~grated pYU~215 and the fir~t, third,
and:fourth band~ corr~pond~to intcrnal fragmont~ from pYUB215
(first) or the chromo~om~l a~d gene (third a~d fourth bands). As
shown~by the arrow, ~h~ cZ:gene (~ -galacto~da~e gane)
fragment i~: the large~t ~and, at about 9.5 kb. All white mutants
show :a ~hift in the ~i~e of:the ~acZ band and an extra ~maller
band. The~ze of th~J~ller band added to the lacZ band
re~ult~ in a:frag~nt of about 11~5 kb ~n length, wh~ch can be
explained by in~rtion of an approximat~ly 2.2 Xb in~ertional
element~(IS-ele~e~t), or tran~poson, which contain~ a BamHI gite,
into the l~cZ gen~.
The in~rtion element which i8 ln~erted in the
-galacto~ida~e gcn4 can b~ recovered ~y cutting total
chromo~omal DNA isolated from a clone containing the in~ertional
element wi~h EcoRI to:completion. EcoRI dlg~etlon will free a
fully func~ional E. colt pla~mid bec~u~o tho ~ g~ne
was cloned into pYVB174 at the EcoRI ~ite. Dlge~tlon with E oRI
.C I ~R~TITI IT~ C~IC~T
~ wo g2/22326 2 ~t ~ 1 2 1 7 PCT/US92/~7~
-31-
will free the origlnal pYU~174 pla~m~d which now contains a copy
of the in~ertion element To i~olate the in~ertlon element,
EcoRI digest~d DNA was ~elf-llgated at a DNA concentration of
les~ than 5 ng~l and tran~formod lnto the E coli ~train DH5
selecting for amplclllln re~iJtanee encoded by the~ -lactama~e
gene carried on pYUB174 On~ clone contalning the in~ertional
element, de~lgnated a~ IS1096, wa~ de~lgnated a~ pYUB209 (Figure
25)
D Characteri~tion of IS1096
~` The approxi~ate po~ltlon~ of elght ln~ertlon~ of IS1096 into
`~ the ~-galactosida~- gene~ re ~hown ln Flgure 26 The
approximately position~ of the elght IS1096 tran~po~ition~ into
the pYUB215~ -gal~cto~Ida~e~ gene wer- deterlned by So~thern
analy~iq Restrlctlon mapping of rS1096 gave the orientation of
the BamHI ~ite w~thin the in~ertion element to allow accurate
approxim~tion of the~po~itlon~ of the in~ertlon~ into the lacZ
g~ene From the dlstributlon of~'ln~ertions ln the
galaeto~id~e gene, IS1096 transpoJe~ ln a random fa~hion
In order to~determIne more accura~ely the frcquency of
IS1096 tran~po~ltlon~in M~ ~meomatl~, 10 lndivld~al colonie~ of
mc2687~were grown~to -tatlonary pha~e~in 5 ml M-ADC-TW wlth
BB;~ kanamycin until ~aturation ~Dilut~on~ of the~e ~0 independent
cuIt~re- were p}ated out~on~M-ADC-KX plate~ such that
approxlmat~ly 1,000~colonie~ per plate were obtained The cells
'from~each culture wero then plated on 20 M-ADC-~X plate~'to
-creen~for whlte coIoni~e~ The number of whlte coIonie~ divided
by~the total nu~ber~of coIonie~ present repre~ent~ the frequency
of~ olation of mutation~ln the ~-galactosida~e gene of mc 687
The~avérag~ freguency o~lo-- of ~-gal~cto~ida~e activity in
the~e culture~ wa~ 7 Z ~ 10 5 per cell Thi~ number lnclude~
only tho~e colonie~ which proved to b~ truly negatlve for
galacto~ida~e actlv~lty~when ~econdarlly ~creened on X-gal
containing plate~ ' ~
Re~trlct~on analy~le of IS1096
f
SUBSTlTUTE SHEET
wo g2,22326 2 1 -1 1 2 1~ -32- PCT/~S92/047 ~
I51096 ln pYUB209 was locat~d wlthln th~ ~-galacto~idase
gene betwcen two HpaI ~ltea To facilitate ~equencing of the
in~ertion element, thic HpaI fragm~nt wa~ cloned in both
orientation~ lnto ~he SmaI slte of pGEM7Zf~ (Pro~og-) Once this
fragment wa~ cloned into ~ Zf~, ~ever~l deletlons were
constructed UQing opportune rlte~ ln IS1096 and the polyl~nker of
IS1096 DeletlonJ were m~de from ~tXI und BumHI ~lte~ within
IS1096 in ~oth dlrections lnto the polylinker of pGEM7Zfl
Having the~o delotlon~ allowed ~oquencing in both dlrections from
these site~ into IS1096 Sequ~ncing of both ~trundr of I51096
and the junction betw~en~IS1096 and pYUB209 was done u~ing
ynthetic oligonucleotide~ as well Sequencing reactions were
carried out u~ing Sequena~e Ver~lon 2 0 (United States
Biochemical Corp ) on double stranded DNA templates, as described
in Kraft, et al ,~Blo Technl~ues, Vol 6, pgs 544-547 (1988)
Southern analy~l~ of Stre~to~Yc-~ coelicolor, E coli strain
K-12, acillu~ subtllu~ and 12 ~pecle~ of mycobacteria wa~
performed u~ing the~n~èrnal IS1096 fragment, ~hown a~ a ~olld
bar between the ~m~I and B~tXI ~ite~ ~hown a~ a graphlc
~ . :
representatlon ln Figure 29, a~ a probe A~ ~hown ln Figure 27,
I51096 ~pre~ent only~ln M ~ ~meomatl~ Thc p-tXo~enic ~trains
of~mycobacteri~a, M tuberculo~i~, M bovi~, M avium, and M
lePrae,~lack~the~ln~ertlon element
Several~dlfferent~M~ ~meomatl- l~olate~, includlng the three
morphotyp~ of M~ ~ omatl~, ~traln ATCC607, were probed by
Southern analy-l-;to~d-t-rmi~ne the degree of variation in
re~trictlon pattern~when~probed with IS1096 Southern analy~is
~ . .
wa~ perfor~ d with~I51096 upon P~tI dige~t~ of total chromo~omal
DNA i~olated from M ~ ~meomati~ mc26, mc222, mc223, mc231, mc232,
and DNA cut wlth HlndIII ~ize ~tandard radlo~ctively labeled)
The blot i~ ~hown ln Flgure 28 Lane 1 1~ ~c26, lane 2 1~ mc222,
lane 3 ls mc223, ~lane~4 l~ mc231, lan~ 5 1~ mc232, and lane 6 i9
~- . : : :
ADNA cut with HlndII~ize ~tandard radloactlvelY labeled As
shown in Flgure 2g, there i~ con~derable var~ablllty in the
dlfferent i~olate~ Only one band appear~ in all of the
~,
,~ .
SUBSTITIJTE SHEET
WO 92/2232~ 2 1 ~ 7 PCI/US92/04706
i~olate~, and the nun~er of inoert1 onal ele~ent~ found ranges
from 8 to 16. Both mc222 and ~ 223 were found to ha~e an
addit~ onal copy of I51096 not pre~ent in mc26.
F. Nucl~otida OQ~U~:~ of IS1096
The se~auence of I S1096 is ~how~ in Fig~are 29 . Sequence
analysi~, caxried out a~ h~reln~ove deDcrlb~d, revealed that
IS1096 i 2275 bp in 1 ~ngth, and th~ percent~ge of guanine and
cytosine ~G~C) ~s 67X, w~lch i~ e~ual to that normally observed
in the M. smec~matis ~:hromoso~e. (W~yno, et ~1., J. Bacteriol.,
Vol . 96, pgs . 1915-1919 ( 15168) ) . Th~ internal regions of I51096
have area~ of higher G~C ranging from about 70X to about 80Z, a~
weI 1 as area~ simi lar to the average G~C cont~nt; however, the
GIC content of the ends of :th~ insertlonal ~lement have a G~C
content of les~ than 60X.
A well con~enred inverted repe~t ~equence i~ ob~erved at
both end3 of IS1096, which is 25 bp ir~ length, i8 indicated in
bold:type in Figure 29. Two mismatcho~ ~re pre~ent in the
inv~rted repeats. Tr~n~po~ltion into th~ ~ -galacto~idase gene
r-sulted in a dupLication of 8 ~p, ~ndlcatQd by underllned bold
type, of tarqet DN~ Jequen~e~ on both ~ides of the in~ert~on
:point. Thi~ duplicstion ~ con~i~tent w~th the mechani~m of
tran~po~ition o~ most inJertlon element~. Thxee ~et~ of inverted
r~epeat~ of approxlmat-ly 9 bp in length were found in the 3' end
of IS1096, the po~itlon~ of which are ~hown ~n Figure 29, a~
de~ignated by psir~ of arrow~ 1~ oppo~ite ori~nt~tion.
Open r~ad~ng rame (ORF) analy~i~ of the ~eguence of IS1096
r-v-aled tho pr~enc~of 13 ORF'~ whl~h ar~ longer than 100 amino
id~ None:of the putatlve ORF'~ dl~played hi~h level~ of
homology to protein- ancoded by other in~ert~on element~;
however, two of the ORE'~ may ~ di~tantly related to previously
sequenced tn~ A tran~po~a~o and tnP R qene~, a~ de~eribed in
Tur~er, et al., Nucl. Acld~ Re~earch, Vol. 17, pg~ 1757 (1989)
and in Rowl~nd, et al., Mol. Mlcro~lol~, Vol. 4, pgs. 961-97S
(1990), a~ hown in Figure 29. A }arge 414 ~mi~o acid ORF with a
,~
::
SUE~STITVTE SHEET
wo 92,22326 2 1 1 1 2 1~ PCT/US92/0470f ~j
-3~-
valine initation codon was found which has 21.1X idcntical and
66X homologous amino aclds over 1~5 amino acids with the
transpo~ase from Tn 3926 (Turner, et al., (1989)). A 237 amino
acid open readtnq fra~e which al~o begtn~ with a valine is in the
opposite direction to the~putative tn~ A gene a~ ~hown in Figure
29 and de~ignated as tnD R. The u~lno terminal 92 amino acids of
tn~ R are 18.5% identlcal ~nd 69% ho~ologoua to the amino
terminu~ of the TnlOOQ re~olva~e. (Reed, et al., Nature, Vol.
300, pg~. 381-383 (1982)j.~ The proteln~ encoded by these ORF'~
are of a similar ~lze~and ~lgniflcantly more ~imilar than the
othcr ORF's found on IS1096 to standard tran~posase and resolvase
proteins. Thl;~ may indlc~te~that such ORE'~ encode proteinq
which are involvcd in~he~tran po ~tlon of IS1096, but are
distantly related to well-characterlzed protein~ known to be
involved in the tranipo~ition of other tran~posons.
EX-~D1~ ~
I51096 is cloned; t~of~M. ~meoma;i~, and a construct is
made~ln~which a -~ ~ enc~thought to encode transposase(s) was
remo~ed from~IS1096~and~réplaced wlth an ach gene (which was
hèreinabove d~cribed).~ The ~quence thought to encode
tran~po~e(~) remain~ln the resulting con~truct but is located
out~ide;of the lnvertod repeat ~eguence-~. The re~ulting
con-truct~ then~c`loned into pGEM7Zf+. The re~ultlng plasmid is
thc~ tran~formed into~M~. ~ovi~-BCG,~and M.bovl~-BCG cell~ are
plated~out~on eomplete~nutrient medium containin~ kanamycin and
el~-cted~;for k~numycin~re~ tance.~ Survl~ing eolonies are those
in;whlch the tranJplo~able~ element ha~ tr~n~po~d from the plasmid
lnto~the BCG chromoJome~ The;tran~po~a~e~ ~gene~) remain~ in the
pla~mid, whlch cannot`repIicate in mycobacteria. The pla~mid,
therefore, will become lo~t. Becau~e the tran~po~a~e gene(~),
whlch remain~ in~the~pla~mld, w~ll become lo~t, the transpo able
element wlll remain ln~the reglon of the BCG chromosome into
which it ln~erted,;~nd will not trun~po~e lnto another region of
~ i ,
SUBSTITUTE SHEET
~ W092/2~26 2 i ~ 7 PCT/VSg2/047~ ?
-35-
the chromo~ome or into any other expres~ion vehicle~ which may
al80 be present ln th~ cell
Upon ~election of ~ur~iving colonle~, ~he colonies may be
~creened for qpeciflc mut-tion~ by platlng on variou~ media
It is to be under~tood, however, that the ~cope of the
pre~nt invention i~ not to be li~lted to the ~peciflc
embodiment~ de~crlbed above The inv~ntlon may be practiced
other than a~ partlcuiarly de~c-lbed and ~till be wlthin the
.
~ cope of the accompanying claim~
.
,
~- .
: ~ :
~ .
-
;
~, ~
,
,
,
:~ :
~'
, ,
SUBSTITUTE SHEET
